{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:34:55Z","timestamp":1776357295116,"version":"3.51.2"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["APP1049906"],"award-info":[{"award-number":["APP1049906"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejpb.2020.01.018","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T02:06:57Z","timestamp":1580522817000},"page":"30-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose"],"prefix":"10.1016","volume":"149","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri G.","family":"Anissimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"van der Hoek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Tsakalozou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanglin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey E.","family":"Grice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.01.018_b0005","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/bph.13059","article-title":"Transdermal patches: history, development and pharmacology","volume":"172","author":"Pastore","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.01.018_b0010","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1007\/s11095-014-1439-7","article-title":"Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay","volume":"31","author":"Lehman","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.01.018_b0015","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1021\/js990053i","article-title":"Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration","volume":"88","author":"Anissimov","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1520-6017(200104)90:4<504::AID-JPS1008>3.0.CO;2-H","article-title":"Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids","volume":"90","author":"Anissimov","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jps.10567","article-title":"Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics","volume":"93","author":"Anissimov","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0030","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/jps.21461","article-title":"Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics","volume":"98","author":"Anissimov","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(96)85199-4","article-title":"Analysis of in vitro skin penetration of acyclovir prodrugs based on a diffusion model with a metabolic process","volume":"135","author":"Bando","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.01.018_b0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0378-5173(80)90115-5","article-title":"A theoretical description relating skin penetration to the thickness of the applied medicament","volume":"6","author":"Guy","year":"1980","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.01.018_b0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jps.20549","article-title":"A two-phase analysis of solute partitioning into the stratum corneum","volume":"95","author":"Nitsche","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1023\/A:1015861709758","article-title":"Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling","volume":"7","author":"Parry","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.01.018_b0055","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jps.20509","article-title":"A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds","volume":"95","author":"Wang","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2125.1998.00045.x","article-title":"Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies","volume":"46","author":"Cross","year":"1998","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.01.018_b0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejpb.2012.04.009","article-title":"Dermal PK\/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling","volume":"81","author":"Bodenlenz","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.01.018_b0070","first-page":"FC11-13","article-title":"Evaluation of skin penetration of diclofenac from a novel topical non aqueous solution: a comparative bioavailability study","author":"Nivsarkar","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejpb.2020.01.018_b0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0278-6915(90)90111-Y","article-title":"In vivo percutaneous absorption of fragrance ingredients in rhesus monkeys and humans","volume":"28","author":"Bronaugh","year":"1990","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2020.01.018_b0080","first-page":"672A","article-title":"Percutaneous absorption of phenols in vivo","volume":"35","author":"Bucks","year":"1987","journal-title":"Clin. Res."},{"key":"10.1016\/j.ejpb.2020.01.018_b0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archderm.1965.01600120093023","article-title":"Penetration of 14c hydrocortisone through normal skin: the effect of stripping and occlusion","volume":"91","author":"Feldmann","year":"1965","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ejpb.2020.01.018_b0090","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jps.2600650934","article-title":"Pharmacokinetics of skin penetration","volume":"65","author":"Cooper","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0095","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jps.2600500403","article-title":"Investigation of some factors influencing percutaneous absorption","volume":"50","author":"Wurster","year":"1961","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1445-5994.1982.tb02485.x","article-title":"Topical bioavailability of methyl salicylate","volume":"12","author":"Roberts","year":"1982","journal-title":"Aust. N Z J. Med."},{"key":"10.1016\/j.ejpb.2020.01.018_b0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1208\/s12248-016-9984-0","article-title":"Mechanistic evaluation of hydration effects on the human epidermal permeation of salicylate esters","volume":"19","author":"Yousef","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.01.018_b0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1248\/bpb.22.281","article-title":"Theoretical analysis of the effect of cutaneous metabolism on skin permeation of parabens based on a two-layer skin diffusion\/metabolism model","volume":"22","author":"Seko","year":"1999","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2020.01.018_b0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF01061455","article-title":"Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance","volume":"17","author":"Siddiqui","year":"1989","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejpb.2020.01.018_b0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(99)00161-1","article-title":"The determination of a diffusional pathlength through the stratum corneum","volume":"188","author":"Bunge","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.01.018_b0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1018981515480","article-title":"A new method for estimating dermal absorption from chemical exposure. 1. General approach","volume":"10","author":"Cleek","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.01.018_b0130","series-title":"The Mathematics of Diffusion","author":"Crank","year":"1975"},{"key":"10.1016\/j.ejpb.2020.01.018_b0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0376-7388(00)82110-9","article-title":"A laplace transform technique for calculating diffusion time lags","volume":"26","author":"Siegel","year":"1986","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1023\/A:1016242821610","article-title":"A new method for estimating dermal absorption from chemical exposure: 2. Effect of molecular weight and octanol-water partitioning","volume":"12","author":"Bunge","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.01.018_b0145","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/1520-6017(200009)89:9<1212::AID-JPS13>3.0.CO;2-4","article-title":"Physiologically relevant two-compartment pharmacokinetic models for skin","volume":"89","author":"McCarley","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0150","series-title":"Topical Drug Bioavailability, Bioequivalence, and Penetration","first-page":"245","article-title":"Mathematical models for topical and transdermal drug products","author":"Anissimov","year":"2014"},{"key":"10.1016\/j.ejpb.2020.01.018_b0155","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.ejpb.2020.01.018_b0160","unstructured":"Tummers B., DataThief III, in, 2006."},{"key":"10.1016\/j.ejpb.2020.01.018_b0165","series-title":"ADAPT 5 User\u2019s Guide:Pharmacokinetic\/Pharmacodynamic Systems Analysis","author":"D\u2019Argenio","year":"2009"},{"key":"10.1016\/j.ejpb.2020.01.018_b0170","first-page":"51","article-title":"Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers","volume":"6","author":"Nagelschmitz","year":"2014","journal-title":"Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.01.018_b0175","unstructured":"U.S. Food and Drug Administration, Guidance for industry: extended release oral dosage forms: development, evaluation, and application of in vitro\/ in vivo correlation. 1997; Available from: http:\/\/www.gmp-compliance.org\/guidemgr\/files\/1306FNL.PDF."},{"key":"10.1016\/j.ejpb.2020.01.018_b0180","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jps.2600531126","article-title":"Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug","volume":"53","author":"Wagner","year":"1964","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0185","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/jps.21035","article-title":"The transient dermal exposure: theory and experimental examples using skin and silicone membranes","volume":"97","author":"Frasch","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1018834021066","article-title":"Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application","volume":"16","author":"Cross","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.01.018_b0195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2165\/00003088-198510020-00004","article-title":"Clinical pharmacokinetics of the salicylates","volume":"10","author":"Needs","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2020.01.018_b0200","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.2042-7158.1993.tb05567.x","article-title":"In-vitro permeability to salicylic acid of human, rodent, and shed snake skin","volume":"45","author":"Harada","year":"1993","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.01.018_b0205","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/1523-1747.ep12475447","article-title":"The influence of skin structure on permeability: an intersite and interspecies comparison with hydrophilic penetrants","volume":"96","author":"Scott","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2020.01.018_b0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jps.2600760608","article-title":"In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method","volume":"76","author":"Rougier","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.01.018_b0215","doi-asserted-by":"crossref","first-page":"856","DOI":"10.5414\/CP202085","article-title":"Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study","volume":"52","author":"Hochel","year":"2014","journal-title":"Int. J. Clin. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:35:33Z","timestamp":1760546133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120300308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":43,"alternative-id":["S0939641120300308"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.01.018","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}